Pages that link to "Q40083279"
Jump to navigation
Jump to search
The following pages link to The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs (Q40083279):
Displaying 16 items.
- Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria (Q24541080) (← links)
- Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects. (Q30249670) (← links)
- Antipsychotic withdrawal symptoms: phenomenology and pathophysiology (Q34560423) (← links)
- Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations. (Q34653803) (← links)
- Neuroleptics in pediatric psychiatry (Q35251965) (← links)
- Psychopharmacological properties of calcium channel inhibitors (Q35283122) (← links)
- Withdrawal akinesia (Q39257544) (← links)
- Multiple dopamine receptors and behavior (Q40090864) (← links)
- Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing (Q41174894) (← links)
- The mechanism of neuroleptic withdrawal (Q41536776) (← links)
- Rebound insomnia after abrupt clozapine withdrawal (Q42550857) (← links)
- Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine (Q42552317) (← links)
- Symptoms of withdrawal from tricyclic antidepressants (Q42822608) (← links)
- Do partial agonists cause akathisia: the role of the mental health nurse who prescribes (Q51891169) (← links)
- A depot neuroleptic withdrawal study neurological effects (Q72558817) (← links)
- Minimal maintenance medication: Effects of three dose schedules on relapse rates and symptoms in chronic schizophrenic outpatients (Q72559598) (← links)